We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

204 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $948M → $1B (+$55.2M)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

8% less funds holding

Funds holding: 222 → 204 (-18)

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
204
Holders Change
-18
Holders Change %
-8.11%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
69
Reduced
68
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$27.3M
2
MC
Maverick Capital
Texas
+$18M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.5M
4
Jennison Associates
Jennison Associates
New York
+$16M
5
State Street
State Street
Massachusetts
+$15.8M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$40M
2
ClearBridge Investments
ClearBridge Investments
New York
-$23.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$8.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$6.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
HPC
176
HM Payson & Co
Maine
$4.02K – – –
Daiwa Securities Group
177
Daiwa Securities Group
Japan
$4K +$1.06K +195 +28%
KFI
178
Key Financial Inc
Pennsylvania
$3.88K – – –
Rockefeller Capital Management
179
Rockefeller Capital Management
New York
$3K – – –
PWMG
180
Prestige Wealth Management Group
New Jersey
$2.1K – – –
LJHT
181
Laurie J. Hall Trustee
$2K -$1.33K -245 -36%
LC
182
Lindbrook Capital
California
$1.47K +$1.3K +239 +412%
US Bancorp
183
US Bancorp
Minnesota
$1.13K +$1.23K +227 New
PNC Financial Services Group
184
PNC Financial Services Group
Pennsylvania
$1.03K – – –
Carson Wealth (CWM LLC)
185
Carson Wealth (CWM LLC)
Nebraska
$1K -$65 -12 -4%
CA
186
Centerpoint Advisors
Massachusetts
$1K – – –
IA
187
IFP Advisors
Florida
$1K – – –
CT
188
Colonial Trust
South Carolina
$666 +$699 +129 New
BBHC
189
Brown Brothers Harriman & Co
New York
$625 – – –
SPIA
190
Steward Partners Investment Advisory
New York
$496 -$98 -18 -15%
FWM
191
Focused Wealth Management
New York
$496 – – –
KFS
192
Kelly Financial Services
Massachusetts
$496 – – –
FGAM
193
Financial Gravity Asset Management
Texas
$493 +$27 +5 New
AWM
194
Accurate Wealth Management
Florida
$457 +$542 +100 New
SWA
195
SOA Wealth Advisors
New York
$332 – – –
CA
196
CoreCap Advisors
Michigan
$332 +$363 +67 New
NMG
197
New Millennium Group
Utah
$298 – – –
HI
198
Harbour Investments
Wisconsin
$253 – – –
S
199
SignatureFD
Georgia
$238 – – –
SSC
200
Syverson Strege & Co
Iowa
$208 – – –
6 7
8
9 10

IMGN Hedge Fund Activity: Q4 2022 in Review

204 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 5.8% from $948M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 27 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 5.8% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.